Early statin use after type 2 diabetes diagnosis linked to lower dementia risk
Source Summary
A study presented at ESC Congress 2026 and published in The Lancet Regional Health – Europe found that early initiation of statins following type 2 diabetes diagnosis was associated with reduced dementia risk. The research demonstrates a potential protective benefit of early statin therapy in diabetic patients.
Why it matters
The finding suggests that early statin therapy may offer cognitive protection for patients with newly diagnosed type 2 diabetes, potentially influencing clinical treatment guidelines.
